SCHEMBL13824223

SCHEMBL13824223

CC(C)(Oc1ccc2c(c1)C(=CCCN1CCC(O)(c3ccc(Cl)cc3)CC1)C1C=CC=NC1CO2)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 9/20 0.38
▸ OPRM1 P35372 5/20 0.36
▸ DRD4 P21917 4/20 0.36
▸ ADRA2A P08913 3/20 0.36
▸ SLC6A4 P31645 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ ADRB2 P07550 2/20 0.36
▸ OPRD1 P41143 2/20 0.36
▸ OPRK1 P41145 2/20 0.36
▸ HTR2B P41595 2/20 0.36
▸ SLC6A3 Q01959 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ SIGMAR1 Q99720 2/20 0.36
▸ HRH2 P25021 2/20 0.36
▸ ADRA1A P35348 2/20 0.36
▸ DRD3 P35462 2/20 0.36
▸ KCNH2 Q12809 2/20 0.36
▸ SCN5A Q14524 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13824226 0.93 CCR1 (0.38) DRD2OPRM1DRD4DRD3ABCB11
SCHEMBL12121715 0.93 CCR1 (0.37) DRD2OPRM1DRD4ADRA2ASLC6A4
SCHEMBL10288236 0.90 ALDH1A1 (0.41) DRD2SLC6A4MEN1LMNAHTR2B
SCHEMBL13617080 0.90 DRD2 (0.36) DRD2DRD4SLC6A4LMNAHTR2B
SCHEMBL13824263 0.89 DRD2 (0.39) DRD2OPRM1DRD4SLC6A4HTR2B
SCHEMBL13824224 0.88 MCHR1 (0.34) DRD2DRD4MEN1KMT2ADRD3
SCHEMBL10287605 0.88 DRD2 (0.41) DRD2OPRM1DRD4SLC6A4HTR2B
SCHEMBL10288248 0.88 DRD2 (0.40) DRD2DRD4SLC6A4MEN1LMNA
SCHEMBL13824429 0.88 ALDH1A1 (0.39) DRD2SLC6A4MEN1LMNAHTR2B
SCHEMBL13616961 0.88 DRD2 (0.36) DRD2DRD4SLC6A4LMNAHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541365-B2 Chemokine receptor antagonists and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. (US) 2009-06-02 — — US disclosed
Send feedback